2Goodman A, SchorgeJ ,Green MF. The long-term effects of in utero exposure-the DES stmy[J]. N Eng!J Med ,2011,364(22) :2083-2084. 被引量：1
3Cooper WO,Hernandez-Diaz S,Arbogast PG,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors[J]. N Eng!J Med,2006,354(23) :2443-2451. 被引量：1
4Walfish A,Al-maawali A,Moretti ME,et al. Teratogenicity of an?giotensin converting enzyme inhibitors or receptor blockers[J].J Obstet Gynaecol,2011 ,31(6) :465-472. 被引量：1
5Li DK,Yang C,Andrade S,et al. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk malformations in offspring: a retrospective cohort study[J]. BMJ , 2011,343 :d5931. 被引量：1
6XIE Y R,CAI D,YU B R,ei al. Primary analysis of some prob-lems in dispensatory and recommendation [ J]. Chin Pharm ,2008,19(4):311-312. 被引量：1
7MIQUEL A V, ORTIN FONT F, MARRUGAT J, et al. Assess-ment of the comprehension of new rephrasing drug package inserts[J]. Med Clin, 2000, 115(11):410417. 被引量：1
8WATSON K T, BARASH P G. The new Food and Drug Adminis-tration drug package insert : implications for patient safety andclinical care[ J]. Anesth Analg, 2009 , 108(1):211-218. 被引量：1
9CHEN H X,DU AN T. Drugs in pregnancy and lactation [ M].Beijing: People's Medical Publishing House,2008 :29-30. 被引量：1
10Ministry of public health rational drugs committee. MCDEX[M]. Chongqing: Chongqing publish-ing company ,2009 :677. 被引量：1
